Botswana Smoking and Abstinence Reinforcement Trial

Enrolling by invitation · Phase 4

Conditions studied: Smoking Cessation, Hiv

In brief

Many people living with HIV in southern Africa, specifically Botswana use tobacco products. Using tobacco makes some of the effects of HIV worse and even causes excess deaths. The investigators plan to use an intervention called Screening, Brief Intervention and Referral to Treatment (SBIRT) to help people to quit smoking and also a drug called varenicline. Apart from helping people to stop smoking, the investigators will also test to see how task shifting can be used to help people stop smoking in a sustainable way. Finally, the investigators will estimate the cost of the intervention.

Key facts

Study ID
NCT05694637
Run by
University of Maryland, Baltimore
People needed
750
Starts
2023-07-25
Expected to finish
2027-08-31
Last updated by the study team
2026-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.